3 results
HPPD-resistant cotton response and weed management systems using isoxaflutole
- Delaney C. Foster, Peter A. Dotray, Corey N. Thompson, Gregory B. Baldwin, Frederick T. Moore
-
- Journal:
- Weed Technology / Volume 36 / Issue 5 / October 2022
- Published online by Cambridge University Press:
- 03 October 2022, pp. 671-677
-
- Article
-
- You have access Access
- Open access
- HTML
- Export citation
-
The southern United States produces 90% of the nation’s cotton, and the Texas High Plains is the largest contiguous cotton producing region. Since 2011, glyphosate-resistant Palmer amaranth has complicated cotton production, and alternatives to glyphosate are needed. Integrating soil residual herbicides into a weed management program is a crucial step to control glyphosate resistant weeds before emergence. The recent development of p-hydroxyphenylpyruvate dioxygenase (HPPD)-resistant cotton by BASF Corporation may allow growers to use isoxaflutole in future weed management programs. In 2019 and 2020, field experiments were conducted in New Deal, Lubbock, and Halfway, Texas, to evaluate HPPD-resistant cotton response to isoxaflutole applied preemergence (PRE) or early postemergence (EPOST) and to determine the efficacy of isoxaflutole when used as part of a season-long weed management program. At the New Deal location, cotton response was observed following the EPOST application, but it never exceeded 10%. Cotton response was greatest following the PRE application in Lubbock in 2019 but did not exceed 14%. In 2020 in Lubbock, cotton was replanted due to severe weather. There was <1% cotton response following the PRE application, and maximum cotton response observed was 9% following EPOST and mid-postemergence (MPOST) applications. Cotton lint yields were not different from those of the nontreated, weed-free control at either location. In non-crop weed control studies in Halfway, all treatments controlled Palmer amaranth ≥94% 21 d after the EPOST application. Twenty-one days after the MPOST treatment, systems with isoxaflutole applied EPOST controlled Palmer amaranth by 88% to 93%, while systems with isoxaflutole PRE controlled Palmer amaranth by 94% to 98%. End-of-season Palmer amaranth control was lowest in the system without isoxaflutole (88%) and when isoxaflutole was used EPOST (88% to 91%). These studies suggest that the use of isoxaflutole in cotton weed management systems may improve season-long control of several troublesome weeds with no adverse effects on cotton yield and quality.
Performance of tank-mix partners with isoxaflutole across the Cotton Belt
- Delaney C. Foster, Peter A. Dotray, Todd A. Baughman, Seth A. Byrd, Alfred S. Culpepper, Darrin M. Dodds, Reagan L. Noland, Scott Nolte, Jason K. Norsworthy, Lawrence E. Steckel, Corey N. Thompson
-
- Journal:
- Weed Technology / Volume 35 / Issue 6 / December 2021
- Published online by Cambridge University Press:
- 09 September 2021, pp. 1014-1022
-
- Article
-
- You have access Access
- Open access
- HTML
- Export citation
-
BASF Corp. has developed p-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitor–resistant cotton and soybean that will allow growers to use isoxaflutole in future weed management programs. In 2019 and 2020, a multi-state non-crop research project was conducted to examine weed control following isoxaflutole applied preemergence alone and with several tank-mix partners at high and low labeled rates. At 28 d after treatment (DAT), Palmer amaranth was controlled ≥95% at six of seven locations with isoxaflutole plus the high rate of diuron or fluridone. These same combinations provided the greatest control 42 DAT at four of seven locations. Where large crabgrass was present, isoxaflutole plus the high rate of diuron, fluridone, pendimethalin, or S-metolachlor or isoxaflutole plus the low rate of fluometuron controlled large crabgrass ≥95% in two of three locations 28 DAT. In two of three locations, isoxaflutole plus the high rate of pendimethalin or S-metolachlor improved large crabgrass control 42 DAT when compared to isoxaflutole alone. At 21 DAT, morningglory was controlled ≥95% at all locations with isoxaflutole plus the high rate of diuron and at three of four locations with isoxaflutole plus the high rate of fluometuron. At 42 DAT at all locations, isoxaflutole plus diuron or fluridone and isoxaflutole plus the high rate of fluometuron improved morningglory control compared to isoxaflutole alone. These results suggest that isoxaflutole applied preemergence alone or in tank mixture is efficacious on a number of cross-spectrum annual weeds in cotton, and extended weed control may be achieved when isoxaflutole is tank-mixed with several soil-residual herbicides.
Contributors
-
- By Douglas L. Arnold, Laura J. Balcer, Amit Bar-Or, Sergio E. Baranzini, Frederik Barkhof, Robert A. Bermel, Francois A. Bethoux, Dennis N. Bourdette, Richard K. Burt, Peter A. Calabresi, Zografos Caramanos, Tanuja Chitnis, Stacey S. Cofield, Jeffrey A. Cohen, Nadine Cohen, Alasdair J. Coles, Devon Conway, Stuart D. Cook, Gary R. Cutter, Peter J. Darlington, Ann Dodds-Frerichs, Ranjan Dutta, Gilles Edan, Michelle Fabian, Franz Fazekas, Massimo Filippi, Elizabeth Fisher, Paulo Fontoura, Corey C. Ford, Robert J. Fox, Natasha Frost, Alex Z. Fu, Siegrid Fuchs, Kazuo Fujihara, Kristin M. Galetta, Jeroen J.G. Geurts, Gavin Giovannoni, Nada Gligorov, Ralf Gold, Andrew D. Goodman, Myla D. Goldman, Jenny Guerre, Stephen L. Hauser, Peter B. Imrey, Douglas R. Jeffery, Stephen E. Jones, Adam I. Kaplin, Michael W. Kattan, B. Mark Keegan, Kyle C. Kern, Zhaleh Khaleeli, Samia J. Khoury, Joep Killestein, Soo Hyun Kim, R. Philip Kinkel, Stephen C. Krieger, Lauren B. Krupp, Emmanuelle Le Page, David Leppert, Scott Litwiller, Fred D. Lublin, Henry F. McFarland, Joseph C. McGowan, Don Mahad, Jahangir Maleki, Ruth Ann Marrie, Paul M. Matthews, Francesca Milanetti, Aaron E. Miller, Deborah M. Miller, Xavier Montalban, Charity J. Morgan, Ichiro Nakashima, Sridar Narayanan, Avindra Nath, Paul W. O’Connor, Jorge R. Oksenberg, A. John Petkau, Michael D. Phillips, J. Theodore Phillips, Tammy Phinney, Sean J. Pittock, Sarah M. Planchon, Chris H. Polman, Alexander Rae-Grant, Stephen M. Rao, Stephen C. Reingold, Maria A. Rocca, Richard A. Rudick, Amber R. Salter, Paula Sandler, Jaume Sastre-Garriga, John R. Scagnelli, Dana J. Serafin, Lynne Shinto, Nancy L. Sicotte, Jack H. Simon, Per Soelberg Sørensen, Ryan E. Stagg, James M. Stankiewicz, Lael A. Stone, Amy Sullivan, Matthew Sutliff, Jessica Szpak, Alan J. Thompson, Bruce D. Trapp, Helen Tremlett, Maria Trojano, Orla Tuohy, Rhonda R. Voskuhl, Marc K. Walton, Mike P. Wattjes, Emmanuelle Waubant, Martin S. Weber, Howard L Weiner, Brian G. Weinshenker, Bianca Weinstock-Guttman, Jeffrey L. Winters, Jerry S. Wolinsky, Vijayshree Yadav, E. Ann Yeh, Scott S. Zamvil
- Edited by Jeffrey A. Cohen, Richard A. Rudick
-
- Book:
- Multiple Sclerosis Therapeutics
- Published online:
- 05 December 2011
- Print publication:
- 20 October 2011, pp viii-xii
-
- Chapter
- Export citation